• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    SC 13D/A 1 cgmgmtllc_20241115x13d.htm SC 13D/A CG Mgmt LLC_2024.11.15_13D
     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13D
    Under the Securities Exchange Act of 1934
    (Amendment No. 16)*
    The Carlyle Group Inc.
    (Name of Issuer)
    Common Stock, par value $0.01
    (Title of Class of Securities)
    14316J108
    (CUSIP Number)
    Jeffrey W. Ferguson
    General Counsel
    The Carlyle Group Inc.
    1001 Pennsylvania Avenue, NW
    Suite 220 South
    Washington, D.C. 20004
    (202) 729-5626
    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    November 14, 2024
    (Date of Event Which Requires Filing of This Statement)
    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this
    Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.   
    ☐
    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.
    See Rule 13d-7 for other parties to whom copies are to be sent.
     
    *
    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
    subject class of securities, and for any subsequent amendment containing information which would alter disclosures
    provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18
    of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be
    subject to all other provisions of the Act (however, see the Notes).
     
     
    CUSIP No. 14316J108
    13D
    Page 2
     
    1
    Names of reporting persons
    Carlyle Group Management L.L.C.
    2
    Check the appropriate box if a member of a group
    (a) ☐  (b) ☐
    3
    SEC use only
    4
    Source of funds (see instructions)
    OO
    5
    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
    ☐
    6
    Citizenship or place of organization
    Delaware
    Number of shares
    beneficially owned by
    each reporting person
    with:
    7
    Sole voting power
    133,870,020
    8
    Shared voting power
    0
    9
    Sole dispositive power
    0
    10
    Shared dispositive power
    0
    11
    Aggregate amount beneficially owned by each reporting person
    133,870,020
    12
    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)
    ☐
    13
    Percent of class represented by amount in Row (11)
    37.4%
    14
    Type of reporting person (see instructions)
    OO (Limited Liability Company)
    CUSIP No. 14316J108
    13D
    Page 3
     
    This Amendment No. 16 to Schedule 13D (“Amendment No. 16”) amends and supplements the Schedule 13D originally filed
    with the United States Securities and Exchange Commission (“SEC”) on January 10, 2020 and amended on February 25,
    2020, May 11, 2020, July 6, 2020, November 17, 2020, January 8, 2021, March 19, 2021, July 13, 2021, July 29, 2021,
    August 6, 2021, August 17, 2021, August 31, 2021, November 19, 2021, June 14, 2022, October 6, 2023, and March 5, 2024
    (as amended to date, the “Schedule 13D”), relating to the common stock, par value $0.01 per share (the “Common Stock”), of
    The Carlyle Group Inc., a Delaware corporation (the “Issuer”). Capitalized terms used herein without definition shall have the
    meaning set forth in the Schedule 13D.
    The Reporting Person may be deemed to be the beneficial owner of shares of Common Stock underlying Proxies that it holds. 
    As of November 14, 2024, the Reporting Person held Proxies with respect to 133,870,020 shares of Common Stock. This
    change in the number of shares of Common Stock underlying the Proxies represents a change in the Reporting Person’s
    beneficial ownership of 1% or more since the last amendment to the Schedule 13D filed by the Reporting Person and
    therefore, the Reporting Person is filing this Amendment No. 16. 
    Item  5.
    Interest in Securities of the Issuer.
    Items 5(a)-(b) of the Schedule 13D are hereby amended and restated in their entirety as follows:
    (a) – (b)
    The following sets forth, as of November 14, 2024, the aggregate number of shares of Common Stock and percentage of
    shares of Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Common Stock as
    to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole
    power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of November 14,
    2024, based on 357,681,261 shares of Common Stock outstanding as of November 14, 2024.
    Reporting Person
    Amount
    beneficially
    owned
    Percent of
    class
    Sole power
    to vote or to
    direct the
    vote
    Shared
    power to
    vote or
    direct the
    vote
    Sole power
    to dispose
    or to direct
    the
    disposition
    Shared
    power to
    dispose or
    to direct the
    disposition
    Carlyle Group Management L.L.C.
    133,870,020
    37.4%
    133,870,020
    0
    0
    0
    The Reporting Person directly holds 0 shares of Common Stock and may be deemed to have sole voting power over
    133,870,020 shares of Common Stock (including the shares underlying the Proxies).
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement
    is true, complete and correct.
    Date: November 15, 2024
     
    CARLYLE GROUP MANAGEMENT L.L.C.
    By:
    /s/ Jeffrey W. Ferguson
    Name:
    Jeffrey W. Ferguson
    Title:
    General Counsel
    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    More analyst ratings

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. disposed of 111,994,953 shares and disposed of 55,557,381 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    1/21/26 4:30:21 PM ET
    $CG
    Investment Managers
    Finance

    New insider Nedelman Jeffrey claimed ownership of 1,499,881 shares (SEC Form 3)

    3 - Carlyle Group Inc. (0001527166) (Issuer)

    1/9/26 5:07:52 PM ET
    $CG
    Investment Managers
    Finance

    New insider Jenkins Mark David claimed ownership of 1,414,484 shares (SEC Form 3)

    3 - Carlyle Group Inc. (0001527166) (Issuer)

    1/9/26 5:06:28 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Resonetics to Acquire Resolution Medical, Expanding Capabilities in Neuromodulation and Structural Heart Markets

    NASHUA, N.H., Jan. 27, 2026 /PRNewswire/ -- Resonetics announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution Medical is headquartered in Fridley, MN, with additional operations in the Netherlands, and is currently owned by Arcline Investment Management. The transaction adds complementary capabilities in high-growth therapeutic markets, including neuromodulation, structural heart, and interventional cardiology to current Resonetics offerings. The

    1/27/26 2:00:00 PM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    12/5/25 4:10:33 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    13F-HR - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:37:43 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-Q filed by The Carlyle Group Inc.

    10-Q - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:11:15 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer

    MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Deborah Ricci as Executive Vice President and Chief Financial Officer (CFO). Ricci joins Acentra Health from Guidehouse Inc., where she most recently served as Partner and Chief Financial & Administrative Officer. In that role, she oversaw finance and accounting functions as well as quality, risk, security, and facilities, while supporting the firm's continued growth and operational transformation. Earlier in her career, Ricci held mu

    1/14/26 9:35:00 AM ET
    $CG
    Investment Managers
    Finance

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle Credit Income Fund Schedules First Quarter 2026 Financial Results and Investor Conference Call

    NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday, February 25, 2026, for its first quarter of 2026. CCIF will host a conference call at 10:00 a.m. EST on Thursday, February 26, 2026, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and a replay will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed

    1/22/26 4:10:00 PM ET
    $CCIF
    $CG
    Finance/Investors Services
    Finance
    Investment Managers

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate